Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs approved the Secure and Fair Enforcement Regulation Banking Act, now known as the SAFER Banking Act of 2023. The bill to open up the financial system to legal cannabis companies now heads to the full Senate for a vote after earlier versions of it were initially introduced on Capitol Hill a decade ago.

Cannabis stock rise as Senate committee OKs cannabis banking bill

TLRY stock pulls back after a recent rally on hopes to ease regulations on cannabis.

Is TLRY Stock A Buy As We Wait For Cannabis To Be Rescheduled?

While Tilray (NASDAQ: TLRY ) is a Canada-headquartered company, TLRY stock will certainly move on changes in U.S. cannabis laws. If you expect to witness cannabis declassification and/or decriminalization in the coming quarters, now is a good time to invest in Tilray.

How U.S. Legal Reforms Could Send This Cannabis Stock Skywards

Aurora Cannabis

SNDL Inc.

The most popular cannabis stocks could see higher highs. The U.S. Department of Health and Human Services wants to downgrade the drug from a Category 1 substance to Category 3.

7 Cannabis Stocks Getting the Most Love on Reddit Now

The North American cannabis market has seen a surge of growth and optimism in 2023, thanks to the favorable political and legal environment. In the past, state-by-state legalization of either the recreational or medical marijuana was the catalyst for new opportunities in the cannabis sector.

Beware! 3 Cannabis Stocks Waving Massive Red Flags Right Now

Through acquisitions, Tilray has become a top company in the U.S. craft beer industry. Those deals can help the business take advantage of opportunities in the cannabis industry as well.

Tilray Brands' CEO Explains Why Beer Is Such a Big Part of the Company's Long-Term Strategy

Village Farms International

The Canadian cannabis industry and top marijuana stocks continue to blaze a trail of opportunity for investors in September 2023, with several top Canadian cannabis companies gaining substantial traction. As the global cannabis market transforms, Canada stays at the vanguard of this booming sector, offering various investment opportunities. In general, the stage is set for investors to profit from the green rush. However, navigating the market with a strategic strategy that combines robust technical analysis and careful risk management is critical.

Navigating the Highs: Canadian Cannabis Stocks in September 2023

Constellation Brands

Valley National

Cannabis stocks soared as rescheduling news made waves this month. The Department of Health and Human Services recommended moving the plant from Schedule I to III.

Marijuana Stocks 2023: 3 Cannabis Names You'll Regret Not Buying Now

NEW YORK and LEAMINGTON, Ontario, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its first quarter ended August 31, 2023 on October 4, 2023.

Tilray Brands, Inc. to Announce First Quarter 2024 Financial Results on October 4, 2023

Tilray is looking to improve its business with a series of acquisitions. Some of the company's recent moves should boost gross margins.

Where Will Tilray Brands Be in 1 Year?

AMC Entertainment

The Beachbody Co.

GameStop

Robinhood

IronNet

Wish

Discovering which meme stocks to avoid can be tricky. These stocks have, for better or worse, become part of the general discussion of the stock market and investments overall.

Don't Fall for These 7 Meme Stocks That Are Heading for a Crash

Montauk Brewing and SweetWater Brewing's Beers Now Available at the Resort's Top Dining Locations Montauk Brewing and SweetWater Brewing's Beers Now Available at the Resort's Top Dining Locations

Tilray's Best-Selling Beers Make Landfall at Atlantis, Bahamas

Despite their somewhat lacklustre results over the last few years, cannabis stocks shouldn't be underestimated. The total return potential of these companies is huge.

Betting Big: 3 Cannabis Stocks Primed for a Breakout

Tilray's acquisition of beverage and beer brands from Anheuser-Busch and Molson Coors solidifies its leadership in the cannabis industry. Despite the struggling cannabis industry, Tilray has only experienced a 16% decline compared to its peers' larger declines. Tilray's focus on its beverage business is expected to overtake its revenue from cannabis, distribution, and wellness segments.

Tilray: North America's Most Transformative Cannabis Company

Tilray Brands Inc shares fell 13% to $2.56 on the Nasdaq Monday after Kerrisdale Capital revealed in a report that it is short the company's stock, describing it as a "failing cannabis player."   Kerrisdale also stated that Tilray is running a "familiar playbook for unsuccessful businesses trading in the public markets.

Tilray Brands stock drops on short seller report

Last Friday, Tilray Brands filed a preliminary proxy statement requesting an increase in the number of authorized shares. In response, the company's shares fell by double digits today.

Why Tilray Brands Stock Is Faltering Today

Cannabis multi-state operator (MSO) stocks are set to end another week on a high on renewed optimism around marijuana banking reform. The Senate Banking Committee is expected to hold a markup session for the Secure and Fair Enforcement (SAFE) Banking Act in the week starting September 25, according to sources with knowledge of the matter.

Cannabis MSO shares rise with marijuana banking reform poised to win Senate Committee's approval

The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work with cannabis companies.

Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27

Montauk's Easy-Drinking and Best-Selling Craft Beers Are Now Available at Major Retailers, Restaurants and Bars Across Georgia Montauk's Easy-Drinking and Best-Selling Craft Beers Are Now Available at Major Retailers, Restaurants and Bars Across Georgia

Montauk Brewing Expands Distribution Beyond the Northeast

The cannabis market is in disarray. In Canada, where the recreational drug was legalized nationwide in 2018, the market has all but collapsed.

The 3 Most Undervalued Cannabis Stocks to Buy in September 2023

Anheuser-Busch InBev

MedMen Enterprises Inc.

Many of the most popular cannabis stocks trade on the Nasdaq, including Canopy Growth, Tilray Brands, and SNDL. These businesses operate in the struggling Canadian pot market amid choking competition.

What Is the Nasdaq's Best Cannabis Stock?

Fortune Brands Innovations Inc

YUM! Brands

Almost two years ago, I wrote about seven stocks to buy whose products and services were in high demand.  What made the story unique is that each company recommended had the word “Brands” as part of their corporate name.

3 Best Stocks to Buy for Investors Building a ‘Brands' Portfolio: 2023 Edition

Scotts Miracle-Gro

The U.S. Department of Health and Human Services recently called for cannabis to move from Schedule I (the most restrictive category) to Schedule III. While the transition hasn't taken effect yet, and rescheduling still falls short of decriminalization, a reclassification would have a major impact on U.S. cannabis stocks.

Rescheduling Marijuana 2023: 3 Cannabis Stocks That Could Skyrocket

After amazing gains Monday, two of these cannabis stocks dropped Tuesday morning -- while one continued to pop. New bills in Congress are adding confusion to the marijuana legalization picture.

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks Are All Over the Map Today

Greenlane Holdings

High Tide

Marijuana stocks are the investment of the future for many reasons. For instance, the legal cannabis industry is still new and developing quickly. It was not long ago when the talks about legal cannabis were a bit taboo. Yet from 2018 to 2023 things have changed in favor of legal cannabis. There has been so much change that more people are interested in investing in cannabis. There has been a rise in the number of people who use legal cannabis. The more people who buy cannabis the better it is for the industry and the companies themselves.

3 Marijuana Stocks To Watch As The Cannabis Industry Continues To Grow

News for Tilray Brands Stock (TLRY)